Form 4 · PFE
Pfizer Chairman & CEO Albert Bourla reports an award of 20 phantom stock units SSP
Albert Bourla, Pfizer's Chairman & CEO and a director, filed a Form 4 on Oct 16, 2026 at 6:52 PM ET reporting transactions on Oct 15, 2026.
The filing reports 20 phantom stock units SSP in a grant or award (code A).
Reporting person
- Albert Bourla, Chairman & CEO and a director (as filed: BOURLA ALBERT)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | A | Phantom Stock Units SSP (derivative) | 20 | $29.44 | Acquired | 783,997 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 16, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Pfizer company file → · More Pfizer filings
Disclosures
- Editor holdings in PFE
- The editor holds no position in Pfizer (PFE). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold PFE.